In hepatoblastoma, METTL3-IGF2BP1 mediated m6A modifcation promotes the inhibition ofCCR4-NOT complex-mediated adenylate deadnylation, which enhances SLC7A11 mRNA stability and expression and inhibits tumor ferroptosis. Here, IGF2BP1 is linked to hepatoblastoma.